Astellas Pharma, Inc. (ALPMY)
15.18
-0.46
(-2.94%)
USD |
OTCM |
Mar 03, 15:59
Astellas Pharma Price : 15.18 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 26.60 |
| Nxera Pharma Co., Ltd. | 5.44 |
| PeptiDream Inc. | 8.76 |
| Stemcell Holdings, Inc. | 0.06 |
| Healios KK | 2.10 |
Price Related Metrics
| PE Ratio | 12.66 |
| PS Ratio | 1.979 |
| Price to Book Value | 2.418 |
| Price to Free Cash Flow | 10.52 |
| Earnings Yield | 7.90% |
| Market Cap | 27.19B |
| Operating PE Ratio | 10.08 |
| Normalized PE Ratio | 12.66 |